Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations.
Client: PHARMAESSENTIA CORPORATION · Firm: THE KPM GROUP DC LLC
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
STEALTH BIOTHERAPEUTICS INC. via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Rare Disease Drug Development Ultra-Rare Disease Definition
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLENO THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
Source: Senate LDA
| FULCRUM THERAPEUTICS, INC. |
| 5 |
| 2022–2023 |
| PHARMAESSENTIA CORPORATION | 5 | 2021–2023 |
| SOLENO THERAPEUTICS INC | 5 | 2023 |
| AEGLEA BIOTHERAPEUTICS, INC. | 4 | 2021–2022 |
| ATAI LIFE SCIENCES N.V. | 4 | 2021–2022 |
| MANNKIND CORPORATION | 4 | 2020–2021 |
| ULTRAGENYX PHARMACEUTICAL | 4 | 2021 |
| REZOLUTE | 3 | 2023 |
| ASTRIA THERAPEUTICS, INC. | 2 | 2023 |
| ORPHAZYME US, INC. | 2 | 2020–2021 |
| SANGAMO THERAPEUTICS, INC | 2 | 2020–2021 |
| ACCELERON PHARMA | 1 | 2021 |
| BIOAGILYTIX LABS, LLC | 1 | 2021 |
| COGNOA, INC. | 1 | 2021 |
| GENSIGHT BIOLOGICS S.A. | 1 | 2023 |
| GRITSTONE ONCOLOGY | 1 | 2021 |
| NATIONAL BOARD FOR CERTIFIED COUNSELORS, INC. AND AFFILIATES | 1 | 2021 |
| RELMADA THERAPEUTICS, INC. | 1 | 2021 |
H.R.1092/S.526 - BENEFIT Act of 2023 H.R. 1350, Camerons Law H.R. 1805 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Taiwan International Solidarity Act
Client: PHARMAESSENTIA CORPORATION · Firm: THE KPM GROUP DC LLC
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
H.R. 485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.1805 - Leos Law S.866 - American Innovation and Jobs Act H.R.2673 - American Innovation and R&D Competitiveness Act of 2023 H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Senate HELP Minority- FDA Modernization H.R. 2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 1350 - Camerons Law S. 1906 - Promising Pathway Act
H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022 (117th) S.46 - American Innovation and Manufacturing Act
H.R.1092/S.526 - BENEFIT Act of 2023 H.R. 1350, Camerons Law H.R. 1805 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Senate HELP Minority- FDA Modernization H.R. 2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 1350 - Camerons Law S. 1906 - Promising Pathway Act
H.R. 4170 - LIFT the BAR Act H.R. 5008 - Health Equity and Access under the Law for Immigrant Families Act of 2023 H.R.1805 - Leo's Law H.R.1350 - Cameron's Law
H.R. 4170 - LIFT the BAR Act H.R. 5008 - Health Equity and Access under the Law for Immigrant Families Act of 2023 H.R.1805 - Leo's Law H.R.1350 - Cameron's Law
H.R. 485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.1805 - Leos Law S.866 - American Innovation and Jobs Act H.R.2673 - American Innovation and R&D Competitiveness Act of 2023 H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
H.R.1092/S.526 - BENEFIT Act of 2023 H.R. 1350, Camerons Law H.R. 1805 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
H.R.1092/S.526 - BENEFIT Act of 2023 H.R. 1350, Camerons Law H.R. 1805 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Securing the U.S. Organ Procurement and Transplantation Network Act
Client: THE BRAIN DONOR PROJECT · Firm: THE KPM GROUP DC LLC
H.R. 2544, the Securing the U.S. Organ Procurement and Transplantation Network Act H.Res.361 - Expressing support for the designation of May 7 each year as "Brain Donation Awareness Day"
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathway Act
Medicaid VBPs for Patients Act
Client: PHARMAESSENTIA CORPORATION · Firm: THE KPM GROUP DC LLC
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
American Innovation and R&D Competitiveness Act of 2023
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathway Act
American Innovation and R&D Competitiveness Act of 2023
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.1805 - Leos Law S.866 - American Innovation and Jobs Act H.R.2673 - American Innovation and R&D Competitiveness Act of 2023 H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Pharmacy Benefits Manager Accountability Act
Client: PHARMAESSENTIA CORPORATION · Firm: THE KPM GROUP DC LLC
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
H.R. 4170 - LIFT the BAR Act H.R. 5008 - Health Equity and Access under the Law for Immigrant Families Act of 2023 H.R.1805 - Leo's Law H.R.1350 - Cameron's Law
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 2471 - Consolidated Appropriations Act, 2022 Rare Disease Drug Development
Protecting Health Care for All Patients Act of 2023
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022 (117th) S.46 - American Innovation and Manufacturing Act
Protecting Health Care for All Patients Act of 2023
Client: CHIESI USA, INC. · Firm: THE KPM GROUP DC LLC
House Energy and Commerce Majority-HR 485 Senate HELP Minority- FDA Modernization
Protecting Health Care for All Patients Act of 2023
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.1805 - Leos Law S.866 - American Innovation and Jobs Act H.R.2673 - American Innovation and R&D Competitiveness Act of 2023 H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
HEAL for Immigrant Families Act of 2023
Client: CHIESI USA, INC. · Firm: THE KPM GROUP DC LLC
H.R. 4170 - LIFT the BAR Act H.R. 5008 - Health Equity and Access under the Law for Immigrant Families Act of 2023 H.R.1805 - Leo's Law H.R.1350 - Cameron's Law
Protecting Americans’ Investments from Woke Policies Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 5339/S. 3131, Orphan Cures Act S. 866, American Innovation and Jobs Act FDA Reform
Taiwan Non-Discrimination Act of 2023
Client: PHARMAESSENTIA CORPORATION · Firm: THE KPM GROUP DC LLC
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
Taiwan Conflict Deterrence Act of 2023
Client: PHARMAESSENTIA CORPORATION · Firm: THE KPM GROUP DC LLC
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathway Act
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
Demanding that the Government of the People's Republic of China and the Chinese Communist Party immediately release Kai Li.
Client: THE BRAIN DONOR PROJECT · Firm: THE KPM GROUP DC LLC
H. Res 1069 (117th)
Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait.
Client: PHARMAESSENTIA CORPORATION · Firm: THE KPM GROUP DC LLC
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
Expressing support for the designation of May 7 each year as "Brain Donation Awareness Day".
Client: THE BRAIN DONOR PROJECT · Firm: THE KPM GROUP DC LLC
H.R. 2544, the Securing the U.S. Organ Procurement and Transplantation Network Act H.Res.361 - Expressing support for the designation of May 7 each year as "Brain Donation Awareness Day"
Expressing support for the designation of May 7 each year as "Brain Donation Awareness Day".
Client: THE BRAIN DONOR PROJECT · Firm: THE KPM GROUP DC LLC
H.Res 361 Expressing support for the designation of May 7 each year as "Brain Donation Awareness Day"
Prescription Pricing for the People Act of 2023
Client: PHARMAESSENTIA CORPORATION · Firm: THE KPM GROUP DC LLC
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
Pharmacy Benefit Manager Transparency Act of 2023
Client: PHARMAESSENTIA CORPORATION · Firm: THE KPM GROUP DC LLC
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathway Act
H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathway Act
Senate HELP Minority- FDA Modernization H.R. 2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 1350 - Camerons Law S. 1906 - Promising Pathway Act
Senate HELP Minority- FDA Modernization H.R. 2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 1350 - Camerons Law S. 1906 - Promising Pathway Act
S.1906 - Promising Pathway Act
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 2471 - Consolidated Appropriations Act, 2022 Rare Disease Drug Development
H.R. 5339/S. 3131, Orphan Cures Act S. 866, American Innovation and Jobs Act FDA Reform
American Innovation and Manufacturing Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022 (117th) S.46 - American Innovation and Manufacturing Act
H.R.1092/S.526 - BENEFIT Act of 2023 H.R. 1350, Camerons Law H.R. 1805 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathway Act
American Innovation and Jobs Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 5339/S. 3131, Orphan Cures Act S. 866, American Innovation and Jobs Act FDA Reform
American Innovation and Jobs Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.1805 - Leos Law S.866 - American Innovation and Jobs Act H.R.2673 - American Innovation and R&D Competitiveness Act of 2023 H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
American Innovation and Jobs Act
Client: ASTRIA THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathway Act
Supporting Best Practices for Healthy Moms Act
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 6888 - The Helping Experts Accelerate Rare Treatments (HEART) Act of 2022 (117th) H.Res.276 - Expressing support for the designation of April 5, 2023, as "Barth Syndrome Awareness Day" H.R.1350 - Camerons Law
Supporting Best Practices for Healthy Moms Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 6216/S. 3389 - Sickle Cell Disease Comprehensive Care Act (117th Congress) H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 (117th Congress) H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.1350 - Camerons Law
Supporting Best Practices for Healthy Moms Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 1350 - Camerons Law H.R. 1805 - Leos Law H.R. 5376 - Inflation Reduction Act of 2022 (117th) H.R. 5539 - ORPHAN Cures Act S. 1214 - RARE Act
Tradeable Performance Standard Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 1350 - Camerons Law H.R. 1805 - Leos Law H.R. 5376 - Inflation Reduction Act of 2022 (117th) H.R. 5539 - ORPHAN Cures Act S. 1214 - RARE Act
Consolidated Appropriations Act, 2022
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Ultra-rare diseases H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress] H.R. 4408/S. 1906 - Promising Pathway Act
Consolidated Appropriations Act, 2022
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 2471 - Consolidated Appropriations Act, 2022 Rare Disease Drug Development
Consolidated Appropriations Act, 2022
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.1805 - Leos Law S.866 - American Innovation and Jobs Act H.R.2673 - American Innovation and R&D Competitiveness Act of 2023 H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Consolidated Appropriations Act, 2022
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress]
Consolidated Appropriations Act, 2022
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
Senate HELP Minority- FDA Modernization H.R. 2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 1350 - Camerons Law S. 1906 - Promising Pathway Act
Consolidated Appropriations Act, 2022
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 6888 - The Helping Experts Accelerate Rare Treatments (HEART) Act of 2022 (117th) H.Res.276 - Expressing support for the designation of April 5, 2023, as "Barth Syndrome Awareness Day" H.R.1350 - Camerons Law
Consolidated Appropriations Act, 2022
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 6216/S. 3389 - Sickle Cell Disease Comprehensive Care Act (117th Congress) H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 (117th Congress) H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.1350 - Camerons Law
Consolidated Appropriations Act, 2022
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
Senate HELP Minority- FDA Modernization H.R. 2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 1350 - Camerons Law S. 1906 - Promising Pathway Act
Consolidated Appropriations Act, 2022
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Consolidated Appropriations Act, 2022
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022 (117th) S.46 - American Innovation and Manufacturing Act
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress]
Carbon Capture Improvement Act of 2021
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Ultra-rare diseases H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress] H.R. 4408/S. 1906 - Promising Pathway Act
Carbon Capture Improvement Act of 2021
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress]
Carbon Capture Improvement Act of 2021
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Rare Disease Drug Development Ultra-Rare Disease Definition
Inflation Reduction Act of 2022
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 1350 - Camerons Law H.R. 1805 - Leos Law H.R. 5376 - Inflation Reduction Act of 2022 (117th) H.R. 5539 - ORPHAN Cures Act S. 1214 - RARE Act
Inflation Reduction Act of 2022
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.1805 - Leos Law S.866 - American Innovation and Jobs Act H.R.2673 - American Innovation and R&D Competitiveness Act of 2023 H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Inflation Reduction Act of 2022
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 6216/S. 3389 - Sickle Cell Disease Comprehensive Care Act (117th Congress) H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 (117th Congress) H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.1350 - Camerons Law
Inflation Reduction Act of 2022
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022 (117th) S.46 - American Innovation and Manufacturing Act
Cosmetic Supply Chain Transparency Act of 2021
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 1350 - Camerons Law H.R. 1805 - Leos Law H.R. 5376 - Inflation Reduction Act of 2022 (117th) H.R. 5539 - ORPHAN Cures Act S. 1214 - RARE Act
Sickle Cell Disease Comprehensive Care Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 6216/S. 3389 - Sickle Cell Disease Comprehensive Care Act (117th Congress) H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 (117th Congress) H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.1350 - Camerons Law
Helping Experts Accelerate Rare Treatments Act of 2022
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Rare Disease Drug Development Ultra-Rare Disease Definition
Helping Experts Accelerate Rare Treatments Act of 2022
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress]
Helping Experts Accelerate Rare Treatments Act of 2022
Client: REZOLUTE · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress]
Helping Experts Accelerate Rare Treatments Act of 2022
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Ultra-rare diseases H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress] H.R. 4408/S. 1906 - Promising Pathway Act
Helping Experts Accelerate Rare Treatments Act of 2022
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 6888 - The Helping Experts Accelerate Rare Treatments (HEART) Act of 2022 (117th) H.Res.276 - Expressing support for the designation of April 5, 2023, as "Barth Syndrome Awareness Day" H.R.1350 - Camerons Law
Helping Experts Accelerate Rare Treatments Act of 2022
Client: CHIESI USA, INC. · Firm: THE KPM GROUP DC LLC
H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress]
Orphan Drug COVID–19 Mitigation Act of 2022
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022 (117th) S.46 - American Innovation and Manufacturing Act
Sickle Cell Disease Treatment Centers Act of 2022
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 6216/S. 3389 - Sickle Cell Disease Comprehensive Care Act (117th Congress) H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 (117th Congress) H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.1350 - Camerons Law
Recognizing the heritage, culture, and contributions of Latinas in the United States.
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 6888 - The Helping Experts Accelerate Rare Treatments (HEART) Act of 2022 (117th) H.Res.276 - Expressing support for the designation of April 5, 2023, as "Barth Syndrome Awareness Day" H.R.1350 - Camerons Law
State Grazing Management Authority Act
Client: RARE DISEASE COMPANY COALITION · Firm: THE KPM GROUP DC LLC
H.R. 1350 - Camerons Law H.R. 1805 - Leos Law H.R. 5376 - Inflation Reduction Act of 2022 (117th) H.R. 5539 - ORPHAN Cures Act S. 1214 - RARE Act
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress]
San Francisco Bay Restoration Act of 2021
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress]
San Francisco Bay Restoration Act of 2021
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Ultra-rare diseases H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress] H.R. 4408/S. 1906 - Promising Pathway Act
San Francisco Bay Restoration Act of 2021
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Rare Disease Drug Development Ultra-Rare Disease Definition
Sickle Cell Disease Comprehensive Care Act
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 6216/S. 3389 - Sickle Cell Disease Comprehensive Care Act (117th Congress) H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 (117th Congress) H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.1350 - Camerons Law
Helping Experts Accelerate Rare Treatments Act of 2022
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Rare Disease Drug Development Ultra-Rare Disease Definition
Helping Experts Accelerate Rare Treatments Act of 2022
Client: REZOLUTE · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress]
Helping Experts Accelerate Rare Treatments Act of 2022
Client: STEALTH BIOTHERAPEUTICS INC. · Firm: THE KPM GROUP DC LLC
H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Ultra-rare diseases H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress] H.R. 4408/S. 1906 - Promising Pathway Act
Helping Experts Accelerate Rare Treatments Act of 2022
Client: CHIESI USA, INC. · Firm: THE KPM GROUP DC LLC
H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress]
Helping Experts Accelerate Rare Treatments Act of 2022
Client: SOLENO THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress]
Sickle Cell Disease Treatment Centers Act of 2022
Client: FULCRUM THERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
H.R. 6216/S. 3389 - Sickle Cell Disease Comprehensive Care Act (117th Congress) H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 (117th Congress) H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.1350 - Camerons Law
Helping Experts Accelerate Rare Treatments Act of 2021
Client: ZAMBON USA · Firm: THE KPM GROUP DC LLC
H.R. 1184 - Helping Experts Accelerate Rare Treatments Act of 2021 S. 4348 - FDASLA Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022
Helping Experts Accelerate Rare Treatments Act of 2021
Client: ZAMBON USA · Firm: THE KPM GROUP DC LLC
H.R. 1184 - Helping Experts Accelerate Rare Treatments Act of 2021 S. 4348 - FDASLA Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022
Helping Experts Accelerate Rare Treatments Act of 2021
Client: CHIESI USA, INC. · Firm: THE KPM GROUP DC LLC
H.R. 1184, Helping Experts Accelerate Rare Treatments Act of 2021 S. 4071, the Helping Experts Accelerate Rare Treatments Act of 2022
Helping Experts Accelerate Rare Treatments Act of 2021
Client: CHIESI USA, INC. · Firm: THE KPM GROUP DC LLC
H.R.5376 - Build Back Better Act H.R.2623 - Camerons Law H.R.6160 - Access to Rare Indications Act of 2021 H.R.1184 - Helping Experts Accelerate Rare Treatments Act of 2021 2416- New Opportunities for Value that Extend Lives Act of 2021 S.350- Newborn Screening Saves Lives Reauthorization Act of 2021 H.R.6963 - Accelerated Approval Integrity Act of 2022 H.R.6996 - Accelerating Access for Patients Act of 2022
Helping Experts Accelerate Rare Treatments Act of 2021
Client: AEGLEA BIOTHERAPEUTICS, INC. · Firm: THE KPM GROUP DC LLC
S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act H.R. 1184, the Helping Experts Accelerate Rare Treatments (HEART) Act S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act H.R. 6000, the Cures 2.0 Act S. 373/H.R. 4472, the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act
H.R.4408/S.1906, Promising Pathway Act FDA Reform H.R. 2471 - Consolidated Appropriations Act, 2022 Rare Disease Drug Development
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REZOLUTE via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
S.1906 - Promising Pathway Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
H.R. 5339/S. 3131, Orphan Cures Act S. 866, American Innovation and Jobs Act FDA Reform
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIESI USA, INC. via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
H.R. 6888/S. 4071, Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress]
Filing targets: HOUSE OF REPRESENTATIVES
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
H.Res 361 Expressing support for the designation of May 7 each year as "Brain Donation Awareness Day"
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRIA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · fourth_quarter · Q4
H.R. 830/S. 1375, HELP Copays Act H.R. 2673, American Innovation and R&D Competitiveness Act of 2023 H.R. 2630/S. 652, Safe Step Act S. 866, American Innovation and Jobs Act S. 1906 Promising Pathway Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
REZOLUTE via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress]
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLENO THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
H.R.4408/S.1906 - Promising Pathway Act H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress]
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STEALTH BIOTHERAPEUTICS INC. via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
H.R. 6888/S. 4071 - Helping Experts Accelerate Rare Treatments (HEART) Act [117th Congress] Ultra-rare diseases H.R. 2471 - Consolidated Appropriations Act, 2022 [117th Congress] H.R. 4408/S. 1906 - Promising Pathway Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FULCRUM THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
FDA Matters
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
H.R. 1350 - Camerons Law H.R. 1805 - Leos Law H.R. 5376 - Inflation Reduction Act of 2022 (117th) H.R. 5539 - ORPHAN Cures Act S. 1214 - RARE Act
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
Introductory meetings on issues related to brain donation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIESI USA, INC. via THE KPM GROUP DC LLC
2023 · third_quarter · Q3
H.R. 4170 - LIFT the BAR Act H.R. 5008 - Health Equity and Access under the Law for Immigrant Families Act of 2023 H.R.1805 - Leo's Law H.R.1350 - Cameron's Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASTRIA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · third_quarter · RR
FDA issues and health care reform
REZOLUTE via THE KPM GROUP DC LLC
2023 · third_quarter · RR
FDA issues and health care reform
SOLENO THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
Senate HELP Minority- FDA Modernization H.R. 2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 1350 - Camerons Law S. 1906 - Promising Pathway Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
STEALTH BIOTHERAPEUTICS INC. via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
Senate HELP Minority- FDA Modernization H.R. 2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 1350 - Camerons Law S. 1906 - Promising Pathway Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
FULCRUM THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
Senate HELP Minority- FDA Modernization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
H.R. 485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.1805 - Leos Law S.866 - American Innovation and Jobs Act H.R.2673 - American Innovation and R&D Competitiveness Act of 2023 H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
H.R. 2544, the Securing the U.S. Organ Procurement and Transplantation Network Act H.Res.361 - Expressing support for the designation of May 7 each year as "Brain Donation Awareness Day"
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMAESSENTIA CORPORATION via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
H.Con.Res.10: Expressing the sense of Congress that the United States should resume normal diplomatic relations with Taiwan, negotiate a bilateral free trade agreement with Taiwan, and support Taiwan's membership in international organizations. H.Res.352: Expressing the sense of the House of Representatives on the importance of a unified transatlantic role in deterring the Chinese Communist Party from disrupting the peace and stability in the Taiwan Strait. H.R. 554: Taiwan Conflict Deterrence Act of 2023 H.R. 2630: Safe Step Act H.R. 540: Taiwan Non-Discrimination Act of 2023 H.R. 2679: Pharmacy Benefits Manager Accountability Act H.R. 830: HELP Copays Act H.R. 2666: MVP Act H.R. 1176: Taiwan International Solidarity Act S. 127: Pharmacy Benefit Manager Transparency Act of 2023 S. 113: Prescription Pricing for the People Act of 2023
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIESI USA, INC. via THE KPM GROUP DC LLC
2023 · second_quarter · Q2
House Energy and Commerce Majority-HR 485 Senate HELP Minority- FDA Modernization
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SOLENO THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.485 - Protecting Health Care for All Patients Act of 2023 H.R.1350 - Camerons Law H.R.8641 - Orphan Drug COVID-19 Mitigation Act of 2022 (117th) S.46 - American Innovation and Manufacturing Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
PHARMAESSENTIA CORPORATION via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
Intro meeting, offer to visit headquarters
Filing targets: HOUSE OF REPRESENTATIVES
STEALTH BIOTHERAPEUTICS INC. via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R. 6888 - The Helping Experts Accelerate Rare Treatments (HEART) Act of 2022 (117th) H.Res.276 - Expressing support for the designation of April 5, 2023, as "Barth Syndrome Awareness Day" H.R.1350 - Camerons Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
FULCRUM THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
H.R. 6216/S. 3389 - Sickle Cell Disease Comprehensive Care Act (117th Congress) H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 (117th Congress) H.R.5376 - Inflation Reduction Act of 2022 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th) H.R.1350 - Camerons Law
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
CHIESI USA, INC. via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
H.R.1092/S.526 - BENEFIT Act of 2023 H.R. 1350, Camerons Law H.R. 1805 (117th) H.R.2471 - Consolidated Appropriations Act, 2022 (117th)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2023 · first_quarter · Q1
H. Res 1069 (117th)
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
GENSIGHT BIOLOGICS S.A. via THE KPM GROUP DC LLC
2023 · first_quarter · RR
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused drug development
SOLENO THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2023 · first_quarter · RR
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused Drug Development
Rare disease drug development Orphan Drug Act Orphan Drug Tax Credit Priority Review Voucher Expedited approval pathways Patient-focused Drug Development
STEALTH BIOTHERAPEUTICS INC. via THE KPM GROUP DC LLC
2022 · fourth_quarter · Q4
H.R. 2617, Consolidated Appropriations Act, 2023 S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2022 · fourth_quarter · Q4
H.R. 2617, the Consolidated Appropriations Act, 2023 S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act of 2022 Public Law 97-414, the Orphan Drug Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2022 · fourth_quarter · Q4
Invitation to office ribbon cutting
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FULCRUM THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2022 · fourth_quarter · Q4
H. RES. 1330 H.R. 6216/S. 3389, the Sickle Cell Disease Comprehensive Care Act H.R. 8855/S. 4866, the Sickle Cell Disease Treatment Centers Act of 2022 S. 1644/H.R. 3761, the Promising Pathway Act S. 373/H.R. 4472, the BENEFIT Act of 2021 H.R.2623, Camerons Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIESI USA, INC. via THE KPM GROUP DC LLC
2022 · fourth_quarter · Q4
H.R. 2617, Consolidated Appropriations Act, 2023 S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022
Filing targets: SENATE
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2022 · fourth_quarter · Q4
House Resolution 1069
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
STEALTH BIOTHERAPEUTICS INC. via THE KPM GROUP DC LLC
2022 · third_quarter · Q3
Orphan drug incentives
Filing targets: SENATE, White House Office
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2022 · third_quarter · Q3
S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act of 2022 Public Law 97-414, the Orphan Drug Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2022 · third_quarter · Q3
H.R. 5376, the Inflation Reduction Act of 2022 H.R. 4436, the Daniel Anderl Judicial Security and Privacy Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIESI USA, INC. via THE KPM GROUP DC LLC
2022 · third_quarter · Q3
S. 4348 - FDASLA Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022 H.R. 5376, the Inflation Reduction Act of 2022 Public Law 97-414, the Orphan Drug Act
H.R. 1184, Helping Experts Accelerate Rare Treatments Act of 2021 S. 4071, the Helping Experts Accelerate Rare Treatments Act of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2022 · third_quarter · Q3
House Resolution 1069
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
STEALTH BIOTHERAPEUTICS INC. via THE KPM GROUP DC LLC
2022 · third_quarter · RR
Developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Advocating to raise awareness of these issues.
FULCRUM THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2022 · third_quarter · RR
Any legislation regarding rare disease treatment
ZAMBON USA via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
S. 2076/H.R. 3932 PASTEUR Act of 2021 H.R. 6000 Cures 2.0 Act
H.R. 1184 - Helping Experts Accelerate Rare Treatments Act of 2021 S. 4348 - FDASLA Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZAMBON USA via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
S. 2076/H.R. 3932 PASTEUR Act of 2021 H.R. 6000 Cures 2.0 Act
H.R. 1184 - Helping Experts Accelerate Rare Treatments Act of 2021 S. 4348 - FDASLA Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
S. 373 H.R. 4472 H.R. 7667 S. 4348 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act S. 373/H.R. 4472, the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act Orphan Drug Tax Credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
S. 2938, the Bipartisan Safer Communities Act H.R. 7667, the Food and Drug Amendments of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIESI USA, INC. via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
H.R.6963 - Accelerated Approval Integrity Act of 2022 H.R.6996 - Accelerating Access for Patients Act of 2022
S. 4348 - FDASLA Act of 2022 H.R. 7667 - Food and Drug Amendments of 2022
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
House Resolution 1069
Filing targets: HOUSE OF REPRESENTATIVES
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2022 · second_quarter · Q2
S. 4348, the FDASLA Act of 2022 H.R. 7667, the Food and Drug Amendments of 2022 S. 4071, the Helping Experts Accelerate Rare Treatments (HEART) Act H.R. 1184, the Helping Experts Accelerate Rare Treatments (HEART) Act S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act H.R. 6000, the Cures 2.0 Act S. 373/H.R. 4472, the Better Empowerment Now to Enhance Framework and Improve Treatments (BENEFIT) Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
H.R. 5989 Precision Medicine Answers for Kids Today Act H.R. 6963 Accelerated Approval Integrity Act of 2022 H.R. 6996 Accelerating Access for Patients Act of 2022 H.R. 5585 Advanced Research Project Agency-Health Act H.R. 4472 BENEFIT Act of 2021
H.R. 5376, the Build Back Better Act H.R. 6000, Cures 2.0 Act H.R. 2623, Camerons Law
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATAI LIFE SCIENCES N.V. via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
Company Drug Development Updates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
House Resolution to establish May 7 as Brain Donation Awareness Day."
Filing targets: HOUSE OF REPRESENTATIVES
CHIESI USA, INC. via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
H.R.5376 - Build Back Better Act H.R.2623 - Camerons Law H.R.6160 - Access to Rare Indications Act of 2021 H.R.1184 - Helping Experts Accelerate Rare Treatments Act of 2021 2416- New Opportunities for Value that Extend Lives Act of 2021 S.350- Newborn Screening Saves Lives Reauthorization Act of 2021 H.R.6963 - Accelerated Approval Integrity Act of 2022 H.R.6996 - Accelerating Access for Patients Act of 2022
H.R.1730 - Speeding Therapy Access Today Act of 2021
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZAMBON USA via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
S. 2076/H.R. 3932 PASTEUR Act of 2021 H.R. 6000 Cures 2.0 Act S. 3799 PREVENT Pandemics Act H.R. 4400 Burn Pit Registry Expansion Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2022 · first_quarter · Q1
Company Drug Development Updates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
H.R. 5376, the Build Back Better Act
Orphan Drug Tax Credit
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
H.R. 5376, the Build Back Better Act H.R. 6000, Cures 2.0 Act H.R. 2623, Camerons Law H.R. 482/S. 350, the Newborn Screening Saves Lives Reauthorization Act
Orphan Drug Tax Credit Accelerated Approval Pathway
Medicare Negotiation
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
PHARMAESSENTIA CORPORATION via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
Company Drug Approval Updates
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
H.R. 5376, the Build Back Better Act Orphan Drug Tax Credit Company Drug Development Updates
Filing targets: SENATE
CHIESI USA, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
Orphan Drug Tax Credit Accelerated Approval Pathway Recommendations S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act
H.R. 6000, Cures 2.0 Act H.R. 5376, the Build Back Better Act H.R. 2623, Camerons Law H.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ATAI LIFE SCIENCES N.V. via THE KPM GROUP DC LLC
2021 · fourth_quarter · Q4
Company Drug Development Updates
Filing targets: HOUSE OF REPRESENTATIVES
COGNOA, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · RR
Market Access and Reimbursement Pediatric Behavioral Health Autism Spectrum Disorder (ASD) Digital Therapeutics/Digital Health AI/ML/IP in Healthcare Clinical Practice Guidelines (CPG) Tricare Comprehensive Autism Care Demonstration (military health)
RELMADA THERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · RR
mental and behavioral health policy proposals and CMS coverage
ZAMBON USA via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
Cures 2.0 (not introduced yet)
Burn Pits Legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
Senate Finance Committee Drug Pricing Principles Orphan Drug Tax Credit
H.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act Build Back Better Act Cures 2.0
Medicare Negotiation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
NIH/NeuroBioBank Appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
CMS Medicare Part D Senior Savings Model
Filing targets: HOUSE OF REPRESENTATIVES
CHIESI USA, INC. via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
FDA Inspections
H.R. 1730/S. 670, the Speeding Therapy Access Today (STAT) Act H.R. 2623, Camerons Law MACPAC Accelerated Approval Pathway Recommendations Cures 2.0 (not introduced yet)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
S. 670/H.R. 1730, the Speeding Therapy Access Today (STAT) Act H.R. 482/ S. 350, the Newborn Screening Saves Lives Reauthorization Act H.R. 3783/S. 2013, the Medical Nutrition Equity Act of 2021 Cures 2.0 (not introduced yet)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · third_quarter · Q3
H.R. 482/ S. 350, the Newborn Screening Saves Lives Speeding Therapy Access Today (STAT) Act - H.R. 1730/S. 670 Ensuring Lasting Smiles Act H.R. 1916/S. 754 HEART Act of 2020 - H.R. 7567 Reauthorization Act Cures 2.0
Fairness in Orphan Drug Exclusivity Act S. 250 Senate Finance Committee Drug Pricing Principles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
H.R. 482/ S.350, the Newborn Screening Saves Lives Reauthorization Act MACPAC Accelerated Approval Pathway Recommendations
Senate Finance Committee Drug Pricing Principles
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL BOARD FOR CERTIFIED COUNSELORS AND AFFILIATES, INC. via THE KPM GROUP DC LLC
2021 · fourth_quarter · RR
Adding mental health counselors as an eligible provider of psychotherapy services under Medicare Part B Increase hiring of mental health counselors by the Department of Veteran's Affairs Increasing funding for SAMHSA's Minority Fellowship Program Ensuring the inclusion of counselors in telehealth measures
Adding mental health counselors as an eligible provider of psychotherapy services under Medicare Part B Increase hiring of mental health counselors by the Department of Veteran's Affairs Increasing funding for SAMHSA's Minority Fellowship Program Ensuring the inclusion of counselors in telehealth measures
RARE DISEASE COMPANY COALITION via THE KPM GROUP DC LLC
2021 · first_quarter · RR
Treatment of rare diseases.
ATAI LIFE SCIENCES N.V. via THE KPM GROUP DC LLC
2021 · second_quarter · 2A
Coverage and Reimbursement for Mental Health Services
DEA Restrictions on Psychedelics
Filing targets: HOUSE OF REPRESENTATIVES
ATAI LIFE SCIENCES N.V. via THE KPM GROUP DC LLC
2021 · second_quarter · RR
DEA Restrictions on Psychedelics; Coverage and Reimbursement for Mental Health Services
DEA Restrictions on Psychedelics; Coverage and Reimbursement for Mental Health Services
THE BRAIN DONOR PROJECT via THE KPM GROUP DC LLC
2021 · second_quarter · RR
Discuss mission to raise awareness for brain donation; increased funding for NIH
PHARMAESSENTIA CORPORATION via THE KPM GROUP DC LLC
2021 · second_quarter · 2A
FDA Foreign Inspections Backlog
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2021 · second_quarter · 2A
CMS Medicare Part D Senior Savings Model
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ZAMBON USA via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
Introductory Meeting; Burn Pits Legislation
Filing targets: HOUSE OF REPRESENTATIVES
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act H.R. 1916/S.754, Ensuring Lasting Smiles Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · second_quarter · Q2
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act Cures 2.0 (not introduced)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOAGILYTIX LABS, LLC via THE KPM GROUP DC LLC
2021 · first_quarter · RR
Cures 2.0, sitting on advisory committees/panels, FDA reform
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
PPE Production through DPA
CMS Medicare Part D Senior Savings Model
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ORPHAZYME US, INC. via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
Filing targets: SENATE
SANGAMO THERAPEUTICS, INC via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, Speeding Therapy Access Today (STAT) Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Filing targets: HOUSE OF REPRESENTATIVES
ACCELERON PHARMA via THE KPM GROUP DC LLC
2021 · first_quarter · RR
drug pricing, rare disease issues, Medicare Part D
drug pricing, rare disease issues, Medicare Part D
PHARMAESSENTIA CORPORATION via THE KPM GROUP DC LLC
2021 · second_quarter · RR
FDA inspections
GRITSTONE ONCOLOGY via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
COVID-19 vaccine development - manufacturing scale-up assistance
Filing targets: SENATE
AEGLEA BIOTHERAPEUTICS, INC. via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act Cures 2.0 (not introduced)
Drug Pricing
Filing targets: HOUSE OF REPRESENTATIVES
OVID THERAPEUTICS via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
Pharma M&A
Filing targets: HOUSE OF REPRESENTATIVES
ULTRAGENYX PHARMACEUTICAL via THE KPM GROUP DC LLC
2021 · first_quarter · Q1
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act H.R. 1916/S.754, Ensuring Lasting Smiles Act Cures 2.0
Drug pricing
Filing targets: HOUSE OF REPRESENTATIVES
MANNKIND CORPORATION via THE KPM GROUP DC LLC
2020 · fourth_quarter · RR
CMS Senior Savings Model and PPE Production through DPA
CMS Senior Savings Model and PPE Production through DPA
SANGAMO THERAPEUTICS, INC via THE KPM GROUP DC LLC
2020 · fourth_quarter · RR
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
Advancing Access to Precision Medicine Act (not introduced) H.R. 1730/S. 670, STAT Act Cures 2.0 (not introduced) PDUFA VII Reauthorization
ORPHAZYME US, INC. via THE KPM GROUP DC LLC
2020 · fourth_quarter · RR
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
H.R. 1730/S. 670, STAT Act H.R. 482/S. 350, Newborn Screening Reauthorization Act
CHIESI USA, INC. via THE KPM GROUP DC LLC
2020 · fourth_quarter · Q4
Priority Review Voucher Program; FDA international inspections
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHIESI USA, INC. via THE KPM GROUP DC LLC
2020 · fourth_quarter · RR
Priority Review Voucher Program; FDA international inspections
ZAMBON USA via THE KPM GROUP DC LLC
2020 · fourth_quarter · Q4
S.3868 - Pandemic Care for Burn Pits Exposure Act of 2020
Filing targets: SENATE